Engineered antibodies that stabilize drug-modified KRASG12C neoantigens enable selective and potent cross-HLA immunotherapy
Year: 2025
Type: article
Language: en
Topic: Monoclonal and Polyclonal Antibodies Research
Authors and affiliations:
raw_author_name: Lorenzo Maso
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA
raw_author_name: Sarah A. Mosure
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA
raw_author_name: Sergio A. Rodriguez-Aponte
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA
raw_author_name: Angelina Pizzo
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA
raw_author_name: Diamond N. Mensah
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA
raw_author_name: Matthew Southard
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA
raw_author_name: Samantha Sze
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA
raw_author_name: Tanvir Ahmed
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA
raw_author_name: Brian Vash
raw_affiliation_strings: Apple Tree Partners, New York, NY, USA
raw_author_name: Takamitsu Hattori
raw_affiliation_strings: Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA
Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA
raw_author_name: Epsa Rajak
raw_affiliation_strings: Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA
raw_author_name: Akiko Koide
raw_affiliation_strings: Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA
Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA
raw_author_name: Benjamin G. Neel
raw_affiliation_strings: Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA
Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA
raw_author_name: Shohei Koide
raw_affiliation_strings: Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA
Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA
raw_author_name: Weifeng Liu
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA
raw_author_name: Sean T. Toenjes
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA
raw_author_name: Paul Da Silva Jardine
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA
Apple Tree Partners, New York, NY, USA
raw_author_name: Rajesh Chopra
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA
Apple Tree Partners, New York, NY, USA
raw_author_name: Christoph Rader
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA. crader@aethontx.com
Aethon Therapeutics, Long Island City, NY, USA
raw_author_name: Lauren E. Stopfer
raw_affiliation_strings: Aethon Therapeutics, Long Island City, NY, USA. lstopfer@aethontx.com
Aethon Therapeutics, Long Island City, NY, USA